Bill > S02000

This bill requires health insurance policies in New York to provide coverage for follow-up screening or diagnostic services for lung cancer without imposing patient cost sharing. Specifically, the bill mandates that health insurance policies must cover follow-up lung cancer screening or diagnostic services when recommended by a healthcare provider and aligned with nationally recognized clinical practice guidelines. These guidelines are defined as evidence-based, peer-reviewed recommendations developed by independent organizations or medical professional societies using a transparent methodology. The bill applies to medical, major medical, and similar comprehensive-type coverage across different types of insurance policies, including individual, group, and commercial plans. The bill includes provisions allowing medical management and utilization review to ensure services are consistent with clinical guidelines, and it provides a special provision for high-deductible health plans that might affect health savings account eligibility. The new requirement will take effect on January 1, 2027, and will apply to all insurance policies issued, renewed, modified, altered, or amended on or after that date, aiming to improve access to lung cancer follow-up screening and diagnostic services without additional financial burden to patients.

Business and Industry

https://www.nysenate.gov/legislation/bills/2025/S2000